FindTrial
Sign In

The diagnostic value of Node-RADS scores based on CT and MRI for axillary lymph Node metastasis of breast cancer

The diagnostic value of Node-RADS scores based on CT and MRI for axillary lymph Node metastasis of breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115464
Enrollment
Unknown
Registered
2025-12-26
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Gold Standard:Pathological examination
Index test:The Node-RADS score of axillary lymph nodes was measured by using enhanced CT of the chest or enhanced MRI of the breast.

Sponsors

Suining Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Diagnosis year: 2013-2025; 2.Gender is not limited; 3.Age >=18 years old; 4.Breast cancer was pathologically confirmed;

Exclusion criteria

Exclusion criteria: 1.The clinical T stages are T4b, T4c, and T4d (inflammatory breast cancer); 2.Combined with infectious diseases; 3.Combined with other malignant tumors; 4.Pathological data of lymph nodes are missing; 5.Complete CT and MRI data are missing; 6. Combined Immune Disorders

Design outcomes

Primary

MeasureTime frame
Accuracy;—

Secondary

MeasureTime frame
Negative predictive value;Sensitivity;Positive predictive value;Specificity;—

Countries

China

Contacts

Public ContactMaoshan Chen

Suining Central Hospital

snscms@126.com+86 825 2292278

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026